Trial of the Use of Doxycycline After Rotator Cuff Repair
NCT ID: NCT02388477
Last Updated: 2016-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Rotator Cuff Tears With Platelet Rich Plasma
NCT06481046
Effects of Dextrose Prolotherapy in Rotator Cuff Disease
NCT04805242
Intra-articular Doxycycline: A Novel Treatment of Adhesive Capsulitis
NCT03479502
Rotator Cuff Healing Using a Nanofiber Scaffold in Patients Greater Than 55 Years
NCT04325789
Treatment of Small Acute Cuff Tears, a Randomized Study
NCT02059473
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Doxycycline
oral doxycycline, 2 weeks, twice a day,
Doxycycline
antibiotic used to treat infection
sugar pill
sugar pill, same size, shape, and color as comparator, twice a day for 2 weeks.
sugar pill
placebo with no pharmacologic effect
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Doxycycline
antibiotic used to treat infection
sugar pill
placebo with no pharmacologic effect
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18 and above
* able to swallow capsules
Exclusion Criteria
* unable to read or understand consent form
* unable to swallow capsules
* allergy to doxycycline
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Milton S. Hershey Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aman Dhawan, MD
Assistant Professor of Surgery, Orthopaedics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aman Dhawan, MD
Role: PRINCIPAL_INVESTIGATOR
Milton S. Hershey Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00002143
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.